logo
Plus   Neg
Share
Email

Dignity PLC H1 Pretax Profit Falls - Quick Facts

Dignity PLC (DTY.L) reported first-half profit before tax of 14.9 million pounds compared to 38.5 million pounds, prior year. Earnings per share was 23.0 pence compared to 61.4 pence. Underlying profit before tax declined to 23.9 million pounds from 43.4 million pounds. Underlying earnings per share was 37.8 pence compared to 69.4 pence.

First-half revenue declined to 153.3 million pounds from 174.7 million pounds, prior year. The number of deaths in the first half was seven percent lower than the same period last year.

Mike McCollum, Chief Executive of Dignity plc, said: "While the number of deaths in the first half meant that our financial performance for the period was lower than originally anticipated, we remain confident that the changes we are introducing will generate sustainable growth in the medium to long-term. Longer-term expectations, based on the ONS forecasts remain unchanged."

For 2019, if deaths were approximately three percent lower than the previous year, the Group projects underlying operating profits could be approximately 3 million pounds to 4 million pounds lower than anticipated at the start of the year. Following completion of the Transformation Plan, the Board continues to believe that targeting solid single digit increases in underlying earnings per share is achievable.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A New York regulator has launched an investigation into the credit card practices of Goldman Sachs Group Inc. for alleged gender discrimination in determining limits for Apple's new credit card, which is administered by Goldman Sachs. The Apple Card, Apple's first credit card, was introduced by the tech giant in March this year in partnership with Goldman Sachs and Mastercard. The U.S. Food and Drug Administration approved the first therapy for patients with a rare inherited blood disorder called beta thalassemia. Celegene's Reblozyl is also the first and only FDA-approved erythroid maturation agent, a new class of therapy for such patients. The regulator approved Reblozyl for treating anemia in adult patients with beta thalassemia who require regular RBC transfusions. McDonald's is adding renewable energy to the grid, as part of its efforts to address climate change. The fast-food giant said it signed two long-term, large-scale virtual power purchase agreements or VPPAs to buy renewable energy generated by wind and solar power. Under the agreements, McDonald's will buy a combined 380MW in renewable energy.
RELATED NEWS
Follow RTT
>